Literature DB >> 16414021

Haemochromatosis gene (HFE) mutations in viral-associated neoplasia: Linkage to cervical cancer.

Carla S Cardoso1, Hélder C Araújo, Eugénia Cruz, Ana Afonso, Cláudia Mascarenhas, Susana Almeida, José Moutinho, Carlos Lopes, Rui Medeiros.   

Abstract

The present study examines the frequency of the two main HFE mutations (C282Y and H63D) in a randomly selected population of 346 individuals including 201 DNA samples from women with cervical neoplasia (including high-grade squamous intraepithelial lesions and invasive squamous cell carcinoma) and a control population of 146 women from the same geographical area. We found a significantly lower risk of development of cervical neoplasia in H63D carriers (OR = 0.56; 95% CI 0.35-0.92; p = 0.01). Multivariate logistic regression analysis confirms this observation (OR = 0.55; 95% CI 0.35-0.88, p = 0.01). Regarding the C282Y mutation no association was found (OR = 1.32; 95% CI 0.53-3.33; p = 0.52). In addition, a significant difference between H63D carrier and non-carrier women on the time-to-onset of cervical lesions was observed (log-rank test: p = 0.0012). These results indicate that HFE could be considered a candidate modifier gene of viral-related neoplasia such as cervical carcinoma possibly by a dual role on iron metabolism and immunological system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414021     DOI: 10.1016/j.bbrc.2005.12.174

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  HFE polymorphisms affect survival of brain tumor patients.

Authors:  Sang Y Lee; Becky Slagle-Webb; Jonas M Sheehan; Junjia Zhu; Joshua E Muscat; Michael Glantz; James R Connor
Journal:  J Neurooncol       Date:  2014-12-10       Impact factor: 4.130

2.  Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer.

Authors:  Hugo Sousa; Sara Oliveira; Alexandra M Santos; Raquel Catarino; José Moutinho; Rui Medeiros
Journal:  Tumour Biol       Date:  2013-11-07

3.  Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G.

Authors:  S Oliveira; J Ribeiro; H Sousa; D Pinto; I Baldaque; R Medeiros
Journal:  Oncol Rep       Date:  2011-12-22       Impact factor: 3.906

Review 4.  Evidence for the Influence of the Iron Regulatory MHC Class I Molecule HFE on Tumor Progression in Experimental Models and Clinical Populations.

Authors:  Cody Weston; James Connor
Journal:  Transl Oncogenomics       Date:  2014-12-04

5.  Association Studies of HFE C282Y and H63D Variants with Oral Cancer Risk and Iron Homeostasis Among Whites and Blacks.

Authors:  Nathan R Jones; Joseph H Ashmore; Sang Y Lee; John P Richie; Philip Lazarus; Joshua E Muscat
Journal:  Cancers (Basel)       Date:  2015-12-09       Impact factor: 6.639

6.  The risk of new-onset cancer associated with HFE C282Y and H63D mutations: evidence from 87,028 participants.

Authors:  Yang-Fan Lv; Xian Chang; Rui-Xi Hua; Guang-Ning Yan; Gang Meng; Xiao-Yu Liao; Xi Zhang; Qiao-Nan Guo
Journal:  J Cell Mol Med       Date:  2016-02-19       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.